Vertex Picks ' Impressive ' Cystic Fibrosis Drugs To Aim For A Multibillion-Dollar Market

Vertex Pharmaceuticals has picked two cystic fibrosis drugs to test in combination with its existing CF medicine, Kalydeco, as part of two different three-drug combinations aimed at helping as many as 90% of patients with cystic fibrosis. (Vertex ' s current offerings can treat half.)
Source: Forbes.com Healthcare News - Category: Pharmaceuticals Authors: Tags: NASDAQ:VRTX Source Type: news